Amedisys’ (AMED) Equal Weight Rating Reaffirmed at Stephens

Amedisys (NASDAQ:AMEDGet Free Report)‘s stock had its “equal weight” rating reiterated by Stephens in a research report issued on Wednesday,Benzinga reports. They presently have a $101.00 target price on the health services provider’s stock. Stephens’ price target indicates a potential upside of 8.97% from the company’s previous close.

Amedisys Stock Performance

AMED stock traded up $0.17 during trading on Wednesday, hitting $92.69. The company had a trading volume of 45,837 shares, compared to its average volume of 268,746. Amedisys has a 1-year low of $82.15 and a 1-year high of $98.95. The firm has a 50-day moving average price of $89.66 and a 200-day moving average price of $93.69. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The firm has a market cap of $3.04 billion, a PE ratio of 36.78, a price-to-earnings-growth ratio of 1.82 and a beta of 0.73.

Hedge Funds Weigh In On Amedisys

Several institutional investors have recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of Amedisys in the fourth quarter valued at about $83,061,000. Wealthfront Advisers LLC acquired a new stake in Amedisys in the fourth quarter valued at about $72,970,000. Pacer Advisors Inc. boosted its holdings in Amedisys by 11,621.9% in the 4th quarter. Pacer Advisors Inc. now owns 558,197 shares of the health services provider’s stock valued at $50,679,000 after purchasing an additional 553,435 shares in the last quarter. Polar Asset Management Partners Inc. acquired a new position in Amedisys during the 3rd quarter worth approximately $28,953,000. Finally, Birnam Oak Advisors LP acquired a new stake in shares of Amedisys in the 4th quarter valued at approximately $15,832,000. 94.36% of the stock is owned by institutional investors and hedge funds.

About Amedisys

(Get Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

See Also

Analyst Recommendations for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.